In a scenario where exogenous angiotensin II is administered with a drug that blocks angiotensin II formation, what best describes the drug’s action?

In a scenario where exogenous angiotensin II is administered with a drug that blocks angiotensin II formation, what best describes the drug’s action?

• A. Full agonist at ATII receptor
• B. Partial agonist at ATII receptor
• C. Competitive antagonist at ATII receptor
• D. Irreversible inhibitor of ACE

Answer: (B)

Partial agonists activate receptors but produce a submaximal response compared with a full agonist. In this scenario, angiotensin II is the full agonist at AT1 receptors, so when a drug that blocks angiotensin II formation is present, any exogenous Ang II can still activate the receptors but to a lesser extent if the blocker acts as a partial agonist. The drug will occupy some receptors and provide only partial signaling, thereby dampening the overall Ang II–mediated effect. It’s not a pure antagonist because it still produces some receptor activity, and it’s not an irreversible ACE inhibitor since the action is at the receptor level, not the enzyme.

Partial agonists activate receptors but produce a submaximal response compared with a full agonist. In this scenario, angiotensin II is the full agonist at AT1 receptors, so when a drug that blocks angiotensin II formation is present, any exogenous Ang II can still activate the receptors but to a lesser extent if the blocker acts as a partial agonist. The drug will occupy some receptors and provide only partial signaling, thereby dampening the overall Ang II–mediated effect. It’s not a pure antagonist because it still produces some receptor activity, and it’s not an irreversible ACE inhibitor since the action is at the receptor level, not the enzyme.